---
schema_version: "secwatch.filing_event.v1"
accession: "0001638833-26-000044"
form_type: "8-K"
ticker: "SGRY"
cik: "0001638833"
company_name: "Surgery Partners, Inc."
filed_at: "2026-05-05T23:59:59+00:00"
generated_at: "2026-05-14T23:24:22.817947+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Surgery Partners Q1 revenue $810.9M (+4.5%), net loss $35.9M; reaffirms FY guidance

## Summary
- Revenue $810.9M (+4.5% YoY); same-facility revenue +4.4% on 0.6% case growth and 3.8% revenue per case.
- Net loss attributable to Surgery Partners $35.9M; Adjusted EBITDA $102.3M vs $103.9M YoY.
- Full-year 2026 guidance reaffirmed: revenue $3.35-3.45B, Adj. EBITDA at least $530M.
- Cash and equivalents $182.3M; revolver capacity $666.1M; net debt/EBITDA ratio 4.3x.
- Operating cash flow $11.7M in Q1 vs $6.0M YoY on working capital timing.

## SEC filing metadata
- accession: 0001638833-26-000044
- form_type: 8-K
- ticker: SGRY
- cik: 0001638833
- company_name: Surgery Partners, Inc.
- filed_at: 2026-05-05T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1638833/000163883326000044/0001638833-26-000044-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1638833/000163883326000044/sgry-20260505.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001638833-26-000044
- JSON: https://secwatch.observer/filing/0001638833-26-000044.json
- Plain text: https://secwatch.observer/filing/0001638833-26-000044.txt

## Source-grounded claims
- claim_id: 068707f3693487fa827bf84ec090a6f555705aeb
  claim: Surgery Partners, Inc. reported Full year 2026 results: revenue $3.35 billion to $3.45 billion. Guidance reaffirmed.
  evidence_excerpt: The Company reaffirmed its outlook for 2026 revenues to be in the range of $3.35 billion to $3.45 billion and Adjusted EBITDA of at least $530 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1638833/000163883326000044/0001638833-26-000044-index.htm
- claim_id: d57cda672af8c178647b37d6e61dbaea397a42b7
  claim: Surgery Partners, Inc. reported first quarter ended March 31, 2026 results: revenue $810.9 million, net income $35.9 million. Guidance reaffirmed.
  evidence_excerpt: return the business to consistent growth, while delivering on long-term shareholder value.” First Quarter 2026 Results Revenues for the first quarter of 2026 increased 4.5% to $810.9 million compared to $776.0 million for the first quarter of 2025. Same-facility revenues for the first quarter of 2026 increased 4.4% as compared to the same period in prior year, with a
  evidence_url: https://www.sec.gov/Archives/edgar/data/1638833/000163883326000044/0001638833-26-000044-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.